早期胎儿生长限制与或没有高血压疾病:临床概述
Federico Mecacci1, Eleonora Romani1, Sara Clemenza2
1Department of Biomedical, Experimental and Clinical Sciences, Division of Obstetrics and Gynecology, University of Florence, Florence, Italy.
Reproductive sciences (Thousand Oaks, Calif.)
|September 8, 2023
概括
早期发作的胎儿生长限制 (FGR) 与妊娠高血压障碍 (HDP) 可能会导致比没有HDP的FGR更糟糕的结果. 本综述比较了这些疾病的临床特征,围产期结果和长期影响.
科学领域:
- 产科和妇科 产科和妇科
- 孕产妇和胎儿医学 孕产妇和胎儿医学
- 新生儿科学 新生儿科学
背景情况:
- 早期发病的胎儿生长限制 (FGR) 是一种与新生儿不良结果相关的重大妊娠并发症.
- 它经常与早期出现的妊娠高血压障碍 (HDP) 一起发生,特别是孕前 (PE).
研究的目的:
- 为了比较临床特征,围产期结局和早期发病的FGR与HDP (FGR-HDP) 和常压FGR (n-FGR) 之间的长期后续.
- 调查PE的存在是否会在早期发病FGR中加剧母亲的血液动力学损伤和胎盘问题.
主要方法:
- 这是一篇综述性文章,综合了有关早期发病FGR-HDP和n-FGR的现有数据.
- 该综述比较了基于当前文献的临床表现,围产期结果和潜在的长期影响.
主要成果:
- 新出现的数据表明,PE可能会在早期发病的FGR中恶化母亲的血液动力学和胎盘病理.
- 与n-FGR相比,具有FGR-HDP的怀孕可能面临新生儿不良后果的风险增加.
结论:
- 区分FGR-HDP和n-FGR对于量身定制的管理和跟进至关重要.
- 需要进一步的研究,以充分阐明这些条件的不同影响和最佳护理策略.
相关概念视频
Teratogenicity
2.5K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.5K
Fetal Circulation
1.0K
Fetal circulation is a unique system that facilitates the exchange of gases, nutrients, and waste products between the developing fetus and the mother. This intricate process takes place through a special organ called the placenta.
Two umbilical arteries transport blood from the fetus to the placenta. At the placenta, the blood absorbs oxygen and nutrients while simultaneously eliminating waste products. This oxygen-enriched and nutrient-rich blood then returns to the fetus through one...
Two umbilical arteries transport blood from the fetus to the placenta. At the placenta, the blood absorbs oxygen and nutrients while simultaneously eliminating waste products. This oxygen-enriched and nutrient-rich blood then returns to the fetus through one...
1.0K
Diabetes Mellitus: Type 2 and Gestational
2.5K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.5K
Pathophysiology of Diabetes
980
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
980
Inborn Errors of Metabolism
185
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
185
Cardiomyopathy III: Hypertrophic Cardiomyopathy
16
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
16


